Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1108 per EA under NDC 64380078707. Its NADAC has been published 207 times since Jun 8, 2022.
FDA first approved this application on Aug 25, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380078707
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202330FDA Approved
8/25/2014
TE Code
AB
On Market Since
2/17/2017
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 207 times since Jun 8, 2022, and over the history we have for it it has declined 49.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1108 per EA |
|---|---|
| All-time high | $0.2189 (Jun 15, 2022) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1212 |
| 52-week low | $0.1108 |
| Median price | $0.1298 |
| Average price | $0.1374 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 207 |
| Tracking since | Jun 8, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.5%
1Y
-6.8%
3Y
-25.1%
5Y
N/A
All
-49.4%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Strides Pharma Inc., is $0.1108 per EA (NDC 64380078707), effective May 20, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 49.4%. It has been tracked across 207 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Jun 8, 2022, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2189 (Jun 15, 2022), with a median of $0.1298 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 64380078707) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.